127 related articles for article (PubMed ID: 28280356)
1. The expression of
Mao Y; Han Y; Shi W
Onco Targets Ther; 2017; 10():1217-1226. PubMed ID: 28280356
[TBL] [Abstract][Full Text] [Related]
2. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
[TBL] [Abstract][Full Text] [Related]
3. Aplasia ras homolog member I is downregulated in gastric cancer and silencing its expression promotes cell growth in vitro.
Tang HL; Hu YQ; Qin XP; Jazag A; Yang H; Yang YX; Yang XN; Liu JJ; Chen JM; Guleng B; Ren JL
J Gastroenterol Hepatol; 2012 Aug; 27(8):1395-404. PubMed ID: 22497484
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of ARHI increases the sensitivity of cervical cancer cells to paclitaxel through inducing apoptosis and autophagy.
Wang Y; Shen F; Zhou J; Fang Y; Qi Y; Chen Y
Drug Dev Res; 2022 Feb; 83(1):142-149. PubMed ID: 34189759
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA RP11-766N7.4 functions as a tumor suppressor by regulating epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
Yao GL; Pan CF; Xu H; Wei K; Liu B; Zhai R; Chen YJ
Biomed Pharmacother; 2017 Apr; 88():778-785. PubMed ID: 28157654
[TBL] [Abstract][Full Text] [Related]
6. The role of aplysia ras homolog I in colon cancer cell invasion and adhesion.
Ouyang J; Pan X; Hu Z
Exp Ther Med; 2017 Nov; 14(5):5193-5199. PubMed ID: 29201236
[TBL] [Abstract][Full Text] [Related]
7. Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating β-catenin signaling pathway.
Xu F; Xu CZ; Gu J; Liu X; Liu R; Huang E; Yuan Y; Zhao G; Jiang J; Xu C; Chu Y; Lu C; Ge D
Oncotarget; 2016 Jul; 7(28):43401-43411. PubMed ID: 27270324
[TBL] [Abstract][Full Text] [Related]
8. TIM-3 promotes the metastasis of esophageal squamous cell carcinoma by targeting epithelial-mesenchymal transition via the Akt/GSK-3β/Snail signaling pathway.
Shan B; Man H; Liu J; Wang L; Zhu T; Ma M; Xv Z; Chen X; Yang X; Li P
Oncol Rep; 2016 Sep; 36(3):1551-61. PubMed ID: 27430162
[TBL] [Abstract][Full Text] [Related]
9. [Effects of microRNA-182-5p on cell proliferation and invasion of esophageal squamous cell carcinoma and related molecular mechanisms].
Zhu ZQ; Hu HF; Zheng XY; Wang F
Zhonghua Zhong Liu Za Zhi; 2020 Aug; 42(8):635-643. PubMed ID: 32867454
[No Abstract] [Full Text] [Related]
10. [Overexpression of aplysia Ras homolog I (ARHI) increases apoptosis in colon cancer SW480 cells].
Chen X; Jiang Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Nov; 32(11):1503-1506. PubMed ID: 27774944
[TBL] [Abstract][Full Text] [Related]
11. Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma.
Yang ZT; Yeo SY; Yin YX; Lin ZH; Lee HM; Xuan YH; Cui Y; Kim SH
PLoS One; 2016; 11(1):e0145807. PubMed ID: 26731558
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of CD9 correlates with tumor stage and lymph node metastasis in esophageal squamous cell carcinoma.
Huan J; Gao Y; Xu J; Sheng W; Zhu W; Zhang S; Cao J; Ji J; Zhang L; Tian Y
Int J Clin Exp Pathol; 2015; 8(3):3054-61. PubMed ID: 26045817
[TBL] [Abstract][Full Text] [Related]
13. Expression and clinical significance of REPS2 in human esophageal squamous cell carcinoma.
Zhang H; Duan CJ; Zhang H; Cheng YD; Zhang CF
Asian Pac J Cancer Prev; 2013; 14(5):2851-7. PubMed ID: 23803043
[TBL] [Abstract][Full Text] [Related]
14. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.
Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW
Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580
[TBL] [Abstract][Full Text] [Related]
15. miR-516b functions as a tumor suppressor by directly modulating CCNG1 expression in esophageal squamous cell carcinoma.
Zhao Y; Wang Y; Xing G
Biomed Pharmacother; 2018 Oct; 106():1650-1660. PubMed ID: 30119241
[TBL] [Abstract][Full Text] [Related]
16. miR-382 functions as a tumor suppressor against esophageal squamous cell carcinoma.
Feng J; Qi B; Guo L; Chen LY; Wei XF; Liu YZ; Zhao BS
World J Gastroenterol; 2017 Jun; 23(23):4243-4251. PubMed ID: 28694664
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of NS1-BP expression in esophageal squamous cell carcinoma].
Ren K; Qian D; Wang YW; Pang QS; Zhang WC; Yuan ZY; Wang P
Zhonghua Zhong Liu Za Zhi; 2018 Jan; 40(1):21-27. PubMed ID: 29365413
[No Abstract] [Full Text] [Related]
18. PTPN9 promotes cell proliferation and invasion in Eca109 cells and is negatively regulated by microRNA-126.
Zhu J; Li H; Ma J; Huang H; Qin J; Li Y
Oncol Lett; 2017 Aug; 14(2):1419-1426. PubMed ID: 28789358
[TBL] [Abstract][Full Text] [Related]
19. [Expression of microRNA-17-5p in esophageal squamous cell carcinoma and its effects on cell proliferation and invasion].
Xu H; Meng XR; Zhou Y; Wang F
Zhonghua Zhong Liu Za Zhi; 2020 Feb; 42(2):105-113. PubMed ID: 32135643
[No Abstract] [Full Text] [Related]
20. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
Wei R; Shang Z; Leng J; Cui L
J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
